Falls Church, VA (PRWEB)
March 19, 2017
Building a World-Class Advertising and Promotion Review Program
**Presented by FDAnews**
FDA marketing scrutiny no longer is limited to magazine and TV ads. Now the agency is poking around, checking signage in tradeshow booths…checking in on Twitter, YouTube and Facebook…and listening to the physicians and other healthcare professionals you’ve paid to speak or train.
In 2016 the Office of Prescription Drug Promotion issued 11 enforcement letters. A 20 percent increase from 2015. Six of those 2016 letters were issued in December alone. What is the meaning of OPDP’s recent upswing in enforcement?
Face it: Manufacturers need help. Not with creating better ads and promotions — they already know how to do that — but for making sure promotional activities aren’t magnets for warning letters.
Come to Arlington in April for two days of intense learning. Attendees will arrive back home with a bag full of tricks and tips to keep all marketing efforts squeaky-clean.
Understanding Pre-Approval Communications: Don’t get on the FDA’s or SEC’s radar screens before a product is even approved. Learn how to properly disclose information and remain in compliance.
- How to Maximize Disease Awareness Communications: Take away valuable tips and tricks for using disease awareness communications pre- and post-approval.
- Hurray! You’re Approved: Build the most aggressive — but compliant — campaign from first day of approval to commercial launch.
- Assuring Your Promotions Meet FDA Off-Label Standards: Successfully navigate 4 major traps that can earn a warning letter fast.
- Itching to do More with Social Media?: Discover how to get the message out there…without…